Summary The response of clonal subpopulations isolated from the RIF-1 mouse sarcoma to melphalan treatment is independent of cell ploidy, whereas a clear relationship exists between ploidy and cell sensitivity to CCNU treatment. In the present study RIF In the present study, we examine whether or not the patterns of drug sensitivity observed for RIF-I clones, when treated in vitro with melphalan and CCNU, are also observed when these clones are treated in vitro with other nitrogen mustards and nitrosoureas. Drugs were selected on the basis of their differing physicochemical and biological activities in an attempt to evaluate the cellular differences responsible for the diverse responses of RIF-1 clones to these agents. For nitrosourea treatment, clones were selected according to their ploidy level; for treatment with nitrogen mustards, clones were selected according to their relative melphalan sensitivity.
It has previously been shown that clonal subpopulations isolated from the RIF-I mouse sarcoma differ markedly in their responses to in vitro treatment with melphalan and CCNU (Reeve et al., 1983b) . No relationship was observed between ploidy levels of RIF-1 clones and melphalan sensitivity; for example the three tetraploid RIF-l clones examined were of resistant, intermediate and sensitive phenotypes and a diploid clone was of intermediate sensitivity. However for CCNU treatment clonal variation in sensitivity was dependent upon ploidy, with diploid clones being more sensitive to treatment than either tetraploid or octoploid clones.
In the present study, we examine whether or not the patterns of drug sensitivity observed for RIF-I clones, when treated in vitro with melphalan and CCNU, are also observed when these clones are treated in vitro with other nitrogen mustards and nitrosoureas. Drugs were selected on the basis of their differing physicochemical and biological activities in an attempt to evaluate the cellular differences responsible for the diverse responses of RIF-1 clones to these agents. For nitrosourea treatment, clones were selected according to their ploidy level; for treatment with nitrogen mustards, clones were selected according to their relative melphalan sensitivity.
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Materials and methods

Tumour cells
The RIF-1 tumour is an X-radiation induced murine sarcoma and by means of flow cytometry and chromosome analysis, has been shown to contain both diploid and tetraploid subpopulations of clonogenic tumour cells (Twentyman et al., 1980) . Details of the in vitro cloning procedures used to produce RIF-I clones of different ploidy are described elsewhere (Reeve & Twentyman. 1983a) . The ploidy levels, as assessed by flow cytometry (Reeve & Twentyman, 1983a) , and the cytotoxic drug sensitivities of RIF-I clones (Reeve et al., 1983b) used in the present study are summarised in Table I In vitro drug treatment Nitrosoureas Diploid (23,28) and tetraploid (16,20) RIF-I clones growing in log phase monolayer culture in 25cm2 tissue culture flasks, were exposed to appropriate concentrations of BCNU, MeCCNU and chlorozotocin (Dr Ven Nararayen, US National Cancer Institute) for 1 h at 37°C. (CCNU (Lundbeck Ltd., Luton) treatment was also repeated in this study to confirm the patterns of sensitivity previously shown by these clones (Table  I) aFrom Reeve et al., 1983b. The medium used throughout was Eagle's Minimal Essential Medium with Earle's Salts supplemented with 10% new born calf serum (Gibco Biocult) and antibiotics.
All drugs were prepared immediately before use and added to the 5 ml of medium overlying the cells in a volume of 0.1 ml. As a control for each drug under study 0.1 ml of the appropriate vehicle alone was added to similar cultures. After treatment the cells were rinsed twice and removed from the tissue culture flasks using trypsin as previously described (Twentyman et al., 1980) , counted and various numbers were plated into replicate petri dishes containing medium. Cells were incubated for 13 days, fixed and stained with crystal violet. Colonies containing at least 50 cells were counted with the aid of a dissecting microscope. In vitro sensitivity of RIF-] (Figure 4) , as was obtained previously with melphalan. However, for chlorambucil and aniline mustard treatment, the survival curve for resistant clone 20 is not exponential like that of clones 16 and 19, but at high doses reaches a constant value (Figures 5, 6 ). following in vitro in vivo and in vitro treatment with the alkylating agents melphalan and CCNU (Reeve et al., 1983b) . For melphalan, drug sensitivity was independent of the ploidy level of individual clones, but for CCNU treatment a clear relationship existed between ploidy and drug sensitivity with tetraploid and octoploid clones being markedly more resistant to drug treatment than diploid clones.
Several possible mechanisms of resistance to alkylating agents have been described including (a) reduced membrane permeability to the drug (e.g. Goldenberg et al., 1970) , (b) reduced drug transport (e.g. Elliott & Ling, 1981; Redwood & Colvin, 1980) , (c) the the presence of enzyme(s) either to circumvent a specific metabolic block or to enhance the capacity for repair of alkylated DNA (e.g. Crathorn & Roberts, 1966; Roberts et al., 1968) , (d) increased cellular concentration of protective agents such as thiols that spare critical target sites from lethal injury by alkylation (e.g. Calcutt & Connors, 1963; Goldenberg, 1969; Hirono, 1960) . In order to elucidate possible cellular mechanisms involved in the patterns of drug sensitivity described above we have exposed RIF-1 clones to selected nitrosoureas and nitrogen mustards which differ significantly in a variety of physicochemical and biological activities. Thus the nitrosoureas were selected on the basis of their different relative alkylating activity versus carbamoylating activity1 and different lipophilicities2 (Wheeler et al., 1974; Wheeler, 1976) . The nitrogen mustards were selected according to their different transport properties (Goldenberg et al., 1970; , lipophilicities and chemical reactivities (Workman et al., 1976) .
The results obtained in the present study show that RIF-1 clones of different ploidy level, when exposed in vitro to nitrosoureas, BCNU, MeCCNU and chlorozotocin, show the same pattern of sensitivity as that previously obtained for CCNU exposure (Reeve et al., 1983b) . This occurs despite the marked differences shown by these drugs in both relative alkylating/carbamoylating activity and lipophilicity (Wheeler et al., 1974; Wheeler, 1976) . Evidence has been presented that BCNU and CCNU are taken up into cells by passive diffusion (Begleiter et al., 1977) . This is also likely to be true for the similarly lipophilic MeCCNU, but may not necessarily apply to the more hydrophilic chlorozotocin, which contains a sugar moeity. Taken over all, it seems unlikely that differences in drug uptake would account for the ploidy dependent drug responses exhibited by RIF-1 clones to nitrosoureas.
As is the case with nitrosoureas, the RIF-1 clones show the same pattern of sensitivity to the different nitrogen mustards, i.e., aniline mustard, chlorambucil and nitrogen mustard itself, as was previously observed with melphalan (Reeve et al., 1983b) . This was true despite the differences in lipophilicity, chemical reactivity (Workman et al., 1976) and perhaps most important, differences in cell transport properties of the nitrogen mustards.
If the comparative resistance of clone 20 to melphalan is a result of reduced efficiency of the amino acid transport system, as is seen with CHO and L1210 resistant variants (Redwood & Colvin, 1980; , one would not expect it also to be resistant to nitrogen mustard, which is actively transported by a different carrier mechanism, the choline transport system, (Goldenberg et al., 1971) or to the nitrogen mustards known or predicted to enter the cell by passive diffusion, respectively chlorambucil and aniline mustard. Thus differences in drug transport can probably be ruled out.
'Nitrosoureas decompose at physiological conditions to yield chloroethyldiazonium hydroxide moieties, which can chloroethylate nucleophiles in nucleic acids, and isocyanates which can react with proteins only be carbamoylation.
2The lipophilicity of a drug measures its relative solubility in water and lipid and is important in determining the ease with which a drug crosses the cell membrane.
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Although the pattern of sensitivity shown by RIF-1 clones in response to treatment with the nitrogen mustards is the same throughout, the shape of the dose-response curve for clone 20 clearly varies with the drug under study. For both melphalan and nitrogen mustard there is an exponential decline in survival with increasing dose; for both aniline mustard and chlorambucil the dose survival curves decrease to a constant value at high doses. The shape of the dose survival curve for clone 20 in response to treatment with aniline mustard and chlorambucil is similar to that obtained for chemotherapeutic agents which kill cells in one portion of the cell cycle, i.e., phase specific agents (Bruce et al., 1966) . One possible interpretation of our data is that the resistance of clone 20 to aniline nEustard and chlorambucil reflects the sensitivity of this clone to these agents in only one part of the cell cycle.
On the basis of the results described here, it seems likely that a common mechanism may predominantly govern the responses of the RIF-l clones to the various nitrosoureas, while a different common mechanism may determine their response to the various nitrogen mustards. Drug uptake is almost certainly not involved and thiol levels and DNA repair capacity appear to us to be the most likely possibilities. It is tempting to speculate, for example, that the ploidy dependence of nitrosourea may be the result of gene dosage for the repair enzyme 06 methylguanine transferase, the suicide enzyme thought to repair the initial chloroethyl adduct which subsequently results in DNA crosslinking (Erikson et al., 1980) . We are currently examining the rate of DNA repair, together with levels of intercellular thiols.
A major problem in cancer therapy is the hetero- 
